The global hematologic cancers testing industry is exhibiting significant expansion, propelled by a rising incidence of lymphoma and other related conditions. Experts estimate the existing market scope to be substantial, with projections indicating a steady compound annual increase rate (CAGR) over the coming period. Key drivers shaping the indu… Read More